Excessive daytime sleepiness (EDS), the primary complaint of patients
seen in sleep clinics, affects up to 12% of the general population. Th
e effects of EDS can be debilitating and even life threatening. Patien
ts with EDS may exhibit psychosocial distress, decreased work or schoo
l performance, and increased risk for accidents. The differential diag
nosis of EDS requires objective assessments, such as polysomnography a
nd the Multiple Sleep Latency Test. There are four major causes of EDS
: (1) central nervous system (CNS) pathologic abnormalities, such as n
arcolepsy and idiopathic CNS hypersomnia; (2) qualitative or quantitat
ive sleep deficiencies, such as sleep apnea and insufficient nocturnal
sleep; (3) misalignments of the body's circadian pacemaker with the e
nvironment (eg, jet lag or shift work); and (4) drugs, which can incre
ase sleepiness either therapeutically or as a side effect. Depending o
n etiology, management strategies for EDS include extension of time in
bed, naps, surgery, various medical devices (eg, oral appliances, con
tinuous positive airway pressure), and pharmacotherapy. Pharmacotherap
y is generally achieved with stimulants, such as amphetamine sulfate,
methylphenidate, and pemoline or newer, safer compounds like modafinil
.